Mr. Alex Stojanovic reports

EMBLEM CORP. ANNOUNCES RECEIPT OF INTERIM COURT ORDER AND MAILING OF MEETING MATERIALS RELATED TO ITS SPECIAL MEETING OF SHAREHOLDERS AND PROPOSED ARRANGEMENT WITH ALEAFIA HEALTH INC.

The Ontario Superior Court of Justice (commercial list) has granted Emblem Corp.'s motion for an interim order authorizing various matters, including the mailing of a management information circular and the holding of the special meeting of Emblem shareholders to be held on March 6, 2019, at 10:30 a.m. Toronto time at the offices of Dentons Canada LLP, 77 King St. West, Suite 400, Toronto, Ont., M5K 0A1.

The meeting will be held to consider the previously announced proposed arrangement involving Emblem and Aleafia Health Inc. described in the joint press release issued by Emblem and Aleafia on Dec. 19, 2018, as well as certain other meeting matters as set out in the circular mailed to shareholders.

The board of directors of Emblem has unanimously recommended that shareholders vote for the arrangement. The directors and chief executive officer and chief financial officer of the company, together with certain shareholders, holding in aggregate approximately 12 per cent of the company's issued and outstanding common shares, have entered into support and voting agreements pursuant to which they have agreed to, among other things, vote their common shares for the arrangement.

Shareholders of record on Jan. 30, 2019, will receive notice of and be entitled to vote at the meeting. Full details of the arrangement, and all other matters to be considered by shareholders at the meeting, are contained in the circular mailed to shareholders and available under the company's SEDAR profile. All shareholders are urged to carefully read the circular and all other materials delivered and filed in connection with the meeting.

On Dec. 16, 2018, the board of directors of the company adopted amended bylaws, which now provide for a 10-per-cent quorum requirement for shareholder meetings and certain other changes pertaining to corporate signing authority, roles of certain officers and the location of the company's registered address. Shareholders will also be asked to confirm and approve the amended bylaws at the meeting.

Any shareholders who have questions about the arrangement or other matters to be considered at the meeting should contact Emblem's strategic shareholder adviser and information agent, Kingsdale Advisors, toll-free at 1-866-581-0508 (toll-free in North America) or at 416-867-2272 (collect outside of North America), or by e-mail at contactus@kingsdaleadvisors.com. Any shareholders who need assistance with the completion and delivery of their proxy or letter of transmittal, please contact Emblem's depositary, Computershare Investor Services Inc. (toll-free in North America), at 1-800-564-6253 or by e-mail at corporateactions@computershare.com.

In addition, the company has entered into an investor relations service agreement with LodeRock Advisors Inc. pursuant to which LodeRock will provide Emblem with strategic investor relations and capital market communications services. LodeRock is a group of senior capital market communications executives, who develop and execute communications programs to help companies achieve their capital market objectives.

The service agreement is for a term of approximately two months, commencing Feb. 4, 2019, and concluding March 31, 2019. Pursuant to the terms of the service agreement, Emblem will pay LodeRock a retainer fee of $30,000, payable in instalments of $10,000 upon execution and on each of Feb. 28, 2019, and March 31, 2019. Emblem has no prior professional relationship with LodeRock, and as of the date of this release, LodeRock does not own or control any securities of the company. The company is also announcing that its previously announced advisory agreement with e.vestor Communications Inc. was terminated as of Dec. 31, 2018.

About Emblem Corp.

Emblem is a fully integrated cannabis company focused on driving shareholder value through product innovation, brand relevance, and access to patient and consumer channels. Through its wholly owned subsidiary Emblem Cannabis Corp., Emblem is licensed to cultivate, process and sell cannabis and cannabis derivatives in Canada under the Cannabis Act. Emblem's state-of-the-art indoor cannabis cultivation facility and product innovation centre is located in Paris, Ont. Emblem is also the parent company of GrowWise Health Ltd., one of Canada's leading cannabis education services.

We seek Safe Harbor.